flurbiprofen has been researched along with tyrosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bhattacharyya, DK; Garavito, M; Lecomte, M; Rieke, CJ; Smith, WL | 1 |
| Kulmacz, RJ; Tsai, AL; Wu, G | 1 |
| Caniglia, S; Impagnatiello, F; L'Episcopo, F; Marchetti, B; Morale, MC; Serra, PA; Testa, N; Tirolo, C | 1 |
| De La Cruz, JP; González-Correa, JA; Guerrero, A; López-Villodres, JA; Muñoz-Marin, J; Reyes, JJ | 1 |
5 other study(ies) available for flurbiprofen and tyrosine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.
Topics: Amino Acid Sequence; Animals; Arachidonic Acid; Arginine; Base Sequence; Binding Sites; Cyclooxygenase Inhibitors; DNA Primers; Enzyme Inhibitors; Flurbiprofen; Glutamates; Ibuprofen; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylpropionates; Prostaglandin-Endoperoxide Synthases; Protein Structure, Tertiary; Sheep; Structure-Activity Relationship; Tyrosine | 1996 |
Cyclooxygenase competitive inhibitors alter tyrosyl radical dynamics in prostaglandin H synthase-2.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; Catalysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Enzyme Activation; Enzyme Stability; Flurbiprofen; Free Radicals; Humans; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thermodynamics; Tyrosine | 2009 |
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Flurbiprofen; Humans; Inflammation; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidoreductases; Parkinson Disease; Rotarod Performance Test; Substantia Nigra; Tyrosine | 2010 |
Lack of enantiomeric influence on the brain cytoprotective effect of ibuprofen and flurbiprofen.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; Cytokines; Cytoprotection; Dinoprostone; Flurbiprofen; Hypoxia, Brain; Ibuprofen; In Vitro Techniques; Lipid Peroxidation; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stereoisomerism; Tyrosine | 2011 |